Paul D. Wes
Pfizer (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Neuroinflammation and Neurodegeneration Mechanisms, Neurobiology and Insect Physiology Research, Parkinson's Disease Mechanisms and Treatments, interferon and immune responses
Most-Cited Works
- → Transcriptomic analysis of purified human cortical microglia reveals age-associated changes(2017)780 cited
- → Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis(2015)679 cited
- → TRPC1, a human homolog of a Drosophila store-operated channel.(1995)623 cited
- → Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model(2011)447 cited
- → Increased glutathione S -transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease(2005)429 cited
- → Drosophila DJ-1 Mutants Are Selectively Sensitive to Environmental Toxins Associated with Parkinson’s Disease(2005)356 cited
- → CX3CR1 Protein Signaling Modulates Microglial Activation and Protects against Plaque-independent Cognitive Deficits in a Mouse Model of Alzheimer Disease(2011)266 cited
- → C. elegans odour discrimination requires asymmetric diversity in olfactory neurons(2001)246 cited
- → Critical data‐based re‐evaluation of minocycline as a putative specific microglia inhibitor(2016)192 cited
- → Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease(2015)186 cited